Found: 212
Select item for more details and to access through your institution.
An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40218-1
- By:
- Publication type:
- Article
Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 13, p. 4642, doi. 10.1007/s00259-022-05916-4
- By:
- Publication type:
- Article
The impact of semi-automatic segmentation methods on metabolic tumor volume, intensity and dissemination radiomics in <sup>18</sup>F-FDG PET scans of patients with classical Hodgkin lymphoma.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.263067
- By:
- Publication type:
- Article
The impact of semi-automatic segmentation methods on metabolic tumor volume, intensity and dissemination radiomics in <sup>18</sup>F-FDG PET scans of patients with classical Hodgkin lymphoma.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263067
- By:
- Publication type:
- Article
Convolutional neural networks for automatic image quality control and EARL compliance of PET images.
- Published in:
- EJNMMI Physics, 2022, v. 9, n. 1, p. 1, doi. 10.1186/s40658-022-00468-w
- By:
- Publication type:
- Article
The impact of semi-automatic segmentation methods on metabolic tumor volume, intensity and dissemination radiomics in <sup>18</sup>F-FDG PET scans of patients with classical Hodgkin lymphoma.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.263067
- By:
- Publication type:
- Article
Dual time point imaging in locally advanced head and neck cancer to assess residual nodal disease after chemoradiotherapy.
- Published in:
- EJNMMI Research, 2022, v. 12, n. 1, p. 1, doi. 10.1186/s13550-022-00905-y
- By:
- Publication type:
- Article
The impact of semi-automatic segmentation methods on metabolic tumor volume, intensity and dissemination radiomics in <sup>18</sup>F-FDG PET scans of patients with classical Hodgkin lymphoma.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263067
- By:
- Publication type:
- Article
The impact of semi-automatic segmentation methods on metabolic tumor volume, intensity and dissemination radiomics in <sup>18</sup>F-FDG PET scans of patients with classical Hodgkin lymphoma.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.121.263067
- By:
- Publication type:
- Article
3D Convolutional Neural Network-Based Denoising of Low-Count Whole-Body 18 F-Fluorodeoxyglucose and 89 Zr-Rituximab PET Scans.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 3, p. 596, doi. 10.3390/diagnostics12030596
- By:
- Publication type:
- Article
The impact of semi-automatic segmentation methods on metabolic tumor volume, intensity and dissemination radiomics in <sup>18</sup>F-FDG PET scans of patients with classical Hodgkin lymphoma.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263067
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET baseline radiomics features improve the prediction of treatment outcome in diffuse large B-cell lymphoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 3, p. 932, doi. 10.1007/s00259-021-05480-3
- By:
- Publication type:
- Article
The impact of semi-automatic segmentation methods on metabolic tumor volume, intensity and dissemination radiomics in <sup>18</sup>F-FDG PET scans of patients with classical Hodgkin lymphoma.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 2, p. 1, doi. 10.2967/jnumed.121.263067
- By:
- Publication type:
- Article
The impact of semi-automatic segmentation methods on metabolic tumor volume, intensity and dissemination radiomics in <sup>18</sup>F-FDG PET scans of patients with classical Hodgkin lymphoma.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 1, p. 1, doi. 10.2967/jnumed.121.263067
- By:
- Publication type:
- Article
18F-FDG PET improves baseline clinical predictors of response in diffuse large B-cell lymphoma: The HOVON-84 study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262205
- By:
- Publication type:
- Article
Quantitative radiomics features in diffuse large B-cell lymphoma: does segmentation method matter?
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262117
- By:
- Publication type:
- Article
First-in-human study of <sup>89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-smallcell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
First-in-human study of <sup>89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-smallcell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262473
- By:
- Publication type:
- Article
Interobserver agreement in automated metabolic tumor volume measurements of Deauville score 4 and 5 lesions at interim 18F‐FDG PET in DLBCL.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.258673
- By:
- Publication type:
- Article
Spatial concordance of DNA methylation classification in diffuse glioma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 12, p. 2054, doi. 10.1093/neuonc/noab134
- By:
- Publication type:
- Article
Diagnostic Performance of [ 18 F]FDG PET in Staging Grade 1–2, Estrogen Receptor Positive Breast Cancer.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 11, p. 1954, doi. 10.3390/diagnostics11111954
- By:
- Publication type:
- Article
18F-FDG PET improves baseline clinical predictors of response in diffuse large B-cell lymphoma: The HOVON-84 study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262205
- By:
- Publication type:
- Article
Quantitative radiomics features in diffuse large B-cell lymphoma: does segmentation method matter?
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262117
- By:
- Publication type:
- Article
First-in-human study of 89Zr-pembrolizumab PET/CT in patients with advanced stage non-small- cell lung cancer . .
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
First-in-human study of 89Zr-pembrolizumab PET/CT in patients with advanced stage non-smallcell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262473
- By:
- Publication type:
- Article
Interobserver agreement in automated metabolic tumor volume measurements of Deauville score 4 and 5 lesions at interim <sup>18</sup>F‐FDG PET in DLBCL.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.258673
- By:
- Publication type:
- Article
Quantitative radiomics features in diffuse large B-cell lymphoma: does segmentation method matter?
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262117
- By:
- Publication type:
- Article
First-in-human study of<sup> 89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262473
- By:
- Publication type:
- Article
Interobserver agreement in automated metabolic tumor volume measurements of Deauville score 4 and 5 lesions at interim 18F‐FDG PET in DLBCL.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.258673
- By:
- Publication type:
- Article
Potential and pitfalls of <sup>89</sup>Zr-immuno-PET to assess target status: <sup>89</sup>Zr-trastuzumab as an example.
- Published in:
- EJNMMI Research, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13550-021-00813-7
- By:
- Publication type:
- Article
Quantitative radiomics features in diffuse large B-cell lymphoma: does segmentation method matter?
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.262117
- By:
- Publication type:
- Article
First-in-human study of <sup>89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.262473
- By:
- Publication type:
- Article
Interobserver agreement in automated metabolic tumor volume measurements of Deauville score 4 and 5 lesions at interim 18F-FDG PET in DLBCL.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.258673
- By:
- Publication type:
- Article
Quantitative radiomics features in diffuse large B-cell lymphoma: does segmentation method matter?
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.121.262117
- By:
- Publication type:
- Article
First-in-human study of <sup>89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
Interobserver agreement in automated metabolic tumor volume measurements of Deauville score 4 and 5 lesions at interim 18F-FDG PET in DLBCL.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.258673
- By:
- Publication type:
- Article
Interobserver agreement in automated metabolic tumor volume measurements of Deauville score 4 and 5 lesions at interim 18F-FDG PET in DLBCL.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 23, doi. 10.2967/jnumed.120.258673
- By:
- Publication type:
- Article
Interobserver agreement in automated metabolic tumor volume measurements of Deauville score 4 and 5 lesions at interim 18F-FDG PET in DLBCL.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.258673
- By:
- Publication type:
- Article
Machine learning-based analysis of [18F]DCFPyL PET radiomics for risk stratification in primary prostate cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 2, p. 340, doi. 10.1007/s00259-020-04971-z
- By:
- Publication type:
- Article
Repeatability of two semi-automatic artificial intelligence approaches for tumor segmentation in PET.
- Published in:
- EJNMMI Research, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13550-020-00744-9
- By:
- Publication type:
- Article
Automated segmentation of baseline metabolic total tumor burden in diffuse large B-cell lymphoma: which method is most successful ?
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.238923
- By:
- Publication type:
- Article
Quantification of PD-L1 expression with [<sup>18</sup>F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article
Repeatability of Quantitative <sup>18</sup>F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.236075
- By:
- Publication type:
- Article
<sup>11</sup>C-sorafenib and <sup>15</sup>O-H<sub>2</sub>O PET for early evaluation of sorafenib therapy.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.251611
- By:
- Publication type:
- Article
Automated segmentation of baseline metabolic total tumor burden in diffuse large B-cell lymphoma: which method is most successful? A study on behalf of the PETRA consortium.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.238923
- By:
- Publication type:
- Article
Quantification of PD-L1 expression with [18F]BMS-986192 PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.240895
- By:
- Publication type:
- Article